Model
Edge
Halozyme Therapeutics, Inc.
0001902866
Filing Type
4
Filing Date
6/13/2024
Updated
6/14/24, 10:17 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership